Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02611661 · ClinicalTrials.gov registry record · Phase 1
Local Ablative Strategies After Endovascular Radioembolization
A Phase 1 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT02611661: Clinical Trial Phase 1 study, sponsored by Washington University School of Medicine.
NCT02611661 is a Phase 1 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 9 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02611661, a Phase 1 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The rationale for this design is initial utilization of a standard-of-care therapy for mCRC (radioembolization) with a dose-calculation algorithm that has been verified as predictive for treatment response. Prediction of treatment failure will enable the proposed subsequent locoregional therapies which were selected based on safety profiles and feasibility. While the goal of this study is assessing feasibility and safety of this approach, the end goal of improving overall patient outcomes by improved hepatic tumor control.
Primary Outcome
* Strata 2, 3, and 4 only * The descriptions and grading scales found in the revised NCI Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 will be utilized for all toxicity reporting.
Interventions
- DEVICE PET/MRI
- RADIATION Stereotactic body radiotherapy
- RADIATION Percutaneous ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2016-01-19 |
| Est. Completion | 2018-02-13 |
| Phase | Phase 1 |
Why NCT02611661 stopped before completion
NCT02611661 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 3 interventions - of which PET/MRI is the first listed.
NCT02611661 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02611661 about?
NCT02611661 is a clinical study titled "Local Ablative Strategies After Endovascular Radioembolization". The rationale for this design is initial utilization of a standard-of-care therapy for mCRC (radioembolization) with a dose-calculation algorithm that has been verified as predictive for treatment response. Prediction of treatment failure will enable the proposed subsequent locoregional therapies wh...
What is the current status of trial NCT02611661?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2016-01-19. Estimated completion is 2018-02-13.
What interventions are being tested in trial NCT02611661?
The interventions under investigation include: PET/MRI (DEVICE), Stereotactic body radiotherapy (RADIATION), Percutaneous ablation (RADIATION).
Who is sponsoring clinical trial NCT02611661?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02611661's enrollment target sits among peer trials
9 1955th of 2000 higher than 42 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI